Related Experiment Videos
Alia Fazza1, Sakina Chemil2, Sawssen Miladi1
1Rheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Insights
Juvenile idiopathic arthritis (JIA) management requires validated tools to assess disease activity and damage. This update reviews key outcome measures for optimizing care and improving quality of life for children with JIA.
Area of Science:
- Pediatric Rheumatology
- Clinical Assessment Tools
- Chronic Childhood Illness
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic condition causing significant morbidity and impacting children's quality of life.
- Effective management of JIA necessitates precise tools for assessing disease activity and damage.
- Optimizing care for children with rheumatic diseases requires validated outcome measures.
Approach:
- This update reviews the primary outcome measures currently employed in JIA patient care.
- Focuses on instruments developed and validated through international collaborative efforts.
- Highlights the importance of dedicated assessment tools for JIA.
Key Points:
- Composite disease activity scores are crucial for monitoring JIA.
- Measures of physical function and health-related quality of life are essential components.
- Clinical damage assessment and Parent and Child Reported Outcomes (PCROs) provide comprehensive patient evaluation.
Conclusions:
- Validated outcome measures are indispensable for optimizing JIA management.
- A comprehensive approach utilizing various assessment tools ensures the best outcomes for children with JIA.
- Continued development and application of these measures are vital for advancing pediatric rheumatology care.
Abstract:
Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant disease- and treatment-related morbidity, thus impacting children's quality of life. In order to optimize JIA management and to ensure the best possible care and outcome for children with rheumatic diseases, dedicated disease activity and damage assessment tools are essential. In recent years, there has been a concerted and important international effort to develop and validate disease activity and outcome instruments specific to JIA. This update aims to describe the main outcome measures currently used in JIA patients. These outcome measures include composite disease activity score, measures of physical function, measures of health related quality of life, clinical measures of damage and the assessment of Parent and child reported outcomes (PCROs).